The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters
BACKGROUND: Saudi Arabia is facing an epidemic of type 2 diabetes that is complicated by a high rate of chronic complications such as kidney disease, which have a major impact on the healthcare system and economy. The Saudi diabetic kidney disease (SAUDI-DKD) study was launched to understand the imp...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
King Faisal Specialist Hospital and Research Centre
2018-01-01
|
| Series: | Annals of Saudi Medicine |
| Online Access: | https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2018.03.01.1010 |
| _version_ | 1819263800762695680 |
|---|---|
| author | Khalid Al-Rubeaan Khalid Siddiqui Mohammed A. Al-Ghonaim Amira M. Youssef Dhekra AlNaqeeb |
| author_facet | Khalid Al-Rubeaan Khalid Siddiqui Mohammed A. Al-Ghonaim Amira M. Youssef Dhekra AlNaqeeb |
| author_sort | Khalid Al-Rubeaan |
| collection | DOAJ |
| description | BACKGROUND: Saudi Arabia is facing an epidemic of type 2 diabetes that is complicated by a high rate of chronic complications such as kidney disease, which have a major impact on the healthcare system and economy. The Saudi diabetic kidney disease (SAUDI-DKD) study was launched to understand the implications of chronic diabetic kidney disease. OBJECTIVES: Examine the hematological, biochemical and metabolic parameters of the selected cohorts to look for biomarkers of diabetic nephropathy. DESIGN: Cross-sectional, hospital-based. SETTING: Four general hospitals and two dialysis centers in Riyadh. PATIENTS AND METHODS: We recruited adult type 2 diabetic patients aged between 35 and 70 years, with a duration of diabetes >10 years, including subjects with microalbuminuria, macroalbuminuria and end stage renal disease (ESRD). They were compared with subjects with normal albumin excretion classified according to American Diabetes Association (ADA) criteria. MAIN OUTCOME MEASURES: The effect of different stages of diabetic nephropathy on hematological and biochemical parameters. RESULTS: Of 427 subjects with nephropathy, 184 (43%) had microalbuminuria, 83 (19%) had macroalbuminuria and 160 (37%) had end stage renal disease (ESRD). The remaining 213 (50%) subjects did not have nephropathy. Patients with nephropathy were older with a mean age (SD) of 55.62 (6.00) years and had a longer duration of diabetes (mean [SD], 19.04 [6.33]) years), and had a lower monthly income and body mass index (BMI) than patients without nephropathy. Insulin resistance, elevated uric acid level, low red blood cells (RBCs) count and low hemoglobin level were associated with significantly increased risk of macroalbuminuria and ESRD. Elevated uric acid and LDH were associated with significantly increased risk of microalbuminuria and ESRD, while elevated red blood cell distribution width was significantly associated with an increased risk of ESRD. CONCLUSION: Diabetic nephropathy is associated with insulin resistance, changes in liver enzymes and uric acid in addition to abnormalities in the red blood cell count and red blood cell shape that warrant frequent monitoring among patients with diabetic kidney disease. LIMITATIONS: Cross-sectional study design and exclusion of patients with some risk factors. |
| first_indexed | 2024-12-23T20:19:21Z |
| format | Article |
| id | doaj.art-240ee33267c247b5b1ace27c460371b1 |
| institution | Directory Open Access Journal |
| issn | 0256-4947 0975-4466 |
| language | English |
| last_indexed | 2024-12-23T20:19:21Z |
| publishDate | 2018-01-01 |
| publisher | King Faisal Specialist Hospital and Research Centre |
| record_format | Article |
| series | Annals of Saudi Medicine |
| spelling | doaj.art-240ee33267c247b5b1ace27c460371b12022-12-21T17:32:35ZengKing Faisal Specialist Hospital and Research CentreAnnals of Saudi Medicine0256-49470975-44662018-01-01381465610.5144/0256-4947.2018.03.01.1010asm-1-46The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parametersKhalid Al-Rubeaan0Khalid Siddiqui1Mohammed A. Al-Ghonaim2Amira M. Youssef3Dhekra AlNaqeeb4From the University Diabetes Center, College of Medicine, King Saud University, Riyadh, Saudi ArabiaFrom the Strategic Center for Diabetes Research, King Saud University, Riyadh, Saudi ArabiaFrom the College of Medicine, King Khalid Universe Hospital, King Saud University, Riyadh Saudi ArabiaFrom the Registry Department, University Diabetes Center, King Saud University, Riyadh, Saudi ArabiaFrom the Research Department, University Diabetes Center, King Saud University, Riyadh, Saudi ArabiaBACKGROUND: Saudi Arabia is facing an epidemic of type 2 diabetes that is complicated by a high rate of chronic complications such as kidney disease, which have a major impact on the healthcare system and economy. The Saudi diabetic kidney disease (SAUDI-DKD) study was launched to understand the implications of chronic diabetic kidney disease. OBJECTIVES: Examine the hematological, biochemical and metabolic parameters of the selected cohorts to look for biomarkers of diabetic nephropathy. DESIGN: Cross-sectional, hospital-based. SETTING: Four general hospitals and two dialysis centers in Riyadh. PATIENTS AND METHODS: We recruited adult type 2 diabetic patients aged between 35 and 70 years, with a duration of diabetes >10 years, including subjects with microalbuminuria, macroalbuminuria and end stage renal disease (ESRD). They were compared with subjects with normal albumin excretion classified according to American Diabetes Association (ADA) criteria. MAIN OUTCOME MEASURES: The effect of different stages of diabetic nephropathy on hematological and biochemical parameters. RESULTS: Of 427 subjects with nephropathy, 184 (43%) had microalbuminuria, 83 (19%) had macroalbuminuria and 160 (37%) had end stage renal disease (ESRD). The remaining 213 (50%) subjects did not have nephropathy. Patients with nephropathy were older with a mean age (SD) of 55.62 (6.00) years and had a longer duration of diabetes (mean [SD], 19.04 [6.33]) years), and had a lower monthly income and body mass index (BMI) than patients without nephropathy. Insulin resistance, elevated uric acid level, low red blood cells (RBCs) count and low hemoglobin level were associated with significantly increased risk of macroalbuminuria and ESRD. Elevated uric acid and LDH were associated with significantly increased risk of microalbuminuria and ESRD, while elevated red blood cell distribution width was significantly associated with an increased risk of ESRD. CONCLUSION: Diabetic nephropathy is associated with insulin resistance, changes in liver enzymes and uric acid in addition to abnormalities in the red blood cell count and red blood cell shape that warrant frequent monitoring among patients with diabetic kidney disease. LIMITATIONS: Cross-sectional study design and exclusion of patients with some risk factors.https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2018.03.01.1010 |
| spellingShingle | Khalid Al-Rubeaan Khalid Siddiqui Mohammed A. Al-Ghonaim Amira M. Youssef Dhekra AlNaqeeb The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters Annals of Saudi Medicine |
| title | The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters |
| title_full | The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters |
| title_fullStr | The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters |
| title_full_unstemmed | The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters |
| title_short | The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters |
| title_sort | saudi diabetic kidney disease study saudi dkd clinical characteristics and biochemical parameters |
| url | https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2018.03.01.1010 |
| work_keys_str_mv | AT khalidalrubeaan thesaudidiabetickidneydiseasestudysaudidkdclinicalcharacteristicsandbiochemicalparameters AT khalidsiddiqui thesaudidiabetickidneydiseasestudysaudidkdclinicalcharacteristicsandbiochemicalparameters AT mohammedaalghonaim thesaudidiabetickidneydiseasestudysaudidkdclinicalcharacteristicsandbiochemicalparameters AT amiramyoussef thesaudidiabetickidneydiseasestudysaudidkdclinicalcharacteristicsandbiochemicalparameters AT dhekraalnaqeeb thesaudidiabetickidneydiseasestudysaudidkdclinicalcharacteristicsandbiochemicalparameters AT khalidalrubeaan saudidiabetickidneydiseasestudysaudidkdclinicalcharacteristicsandbiochemicalparameters AT khalidsiddiqui saudidiabetickidneydiseasestudysaudidkdclinicalcharacteristicsandbiochemicalparameters AT mohammedaalghonaim saudidiabetickidneydiseasestudysaudidkdclinicalcharacteristicsandbiochemicalparameters AT amiramyoussef saudidiabetickidneydiseasestudysaudidkdclinicalcharacteristicsandbiochemicalparameters AT dhekraalnaqeeb saudidiabetickidneydiseasestudysaudidkdclinicalcharacteristicsandbiochemicalparameters |